OBO_ID (LABEL):	GO_0001503 (ossification)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1247491	8/2004	S7-PMC1247491	['when depletion occurs early in Pregnancy, fetal Brain Formation can be markedly altered.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('GO_0001503', 'ossification', 48, 'brain formation'), ('UBERON_0000955', 'brain', 48, 'brain')]
PMC2841444	2/2010	S26-PMC2841444	['caption (table-wrap): table 1\n\nlist of interventionsselectedinterventionsselectedinterventions group 1:interventions given before Pregnancygroup 5:Intrapartum interventions to prevent Stillbirth Xbirth spacingxbirth preparednessxpericonceptional Folatexuse of partogramxindoor air pollution controlxfetal movement monitoringprevention of Female Genital Mutilationxemergency obstetric carexcesarean section for breech presentation group 2:interventions given during Pregnancy Xelective induction of Labor for post-term deliveryxsmoking cessation programsxelective induction of term promxbalanced protein energy supplementationxhome delivery vs. facility deliveryxmultiple Micronutrient supplementationinstrumental Deliveries (forceps versus vacuum)xiron and Folate supplementationamnioinfusionxzinc supplementationcervical Ripening and induction of labor with diff erentxmagnesium Sulfate supplementationprostaglandinsxcalcium supplementationcox Inhibitors for preterm laborxsupplementation with Long-Chain polyunsaturated Fatty Acidsmagnesium Sulphate for treatment of Preeclampsia/eclampsia orxcardiotocographic monitoringpreterm laborxdoppler and late ultrasound monitoringmaternal hyperoxygenationanti-Platelet Agents in Pregnancy, including Aspirinanti-malarials group 6:antepartum and Intrapartum interventions to improve preterm survival Anti-Oxidantsxprophylactic Corticosteroid therapy in Preterm laborvitamin A/Beta-Carotene supplementationxantibiotics for prom/ppromxantibiotics for Preterm labor with intact membranes group 3:interventions for Pregnancy infections xdelayed cord clampingxscreening and treatment of syphilisvitamin a to the motherxintermittent presumptive treatment during Pregnancy (iptp) for malariaxinsecticide-treated mosquito nets (itns) group 7:Postnatal interventions to improve preterm survival xscreening and treatment of asymptomatic bacteriuriaxneonatal resuscitationxscreening and treatment of bacterial vaginosisxvitamin a supplementationxprevention of Mother-To-Child Transmission of hivxvitamin K supplementationxanti-helminthic treatmentxzinc supplementationxscreening and treatment of Periodontal diseasexselenium supplementationxchlorhexidine treatment on the cord group 4:interventions for Pregnancies with high-risks of ptb or sb xcase management of neonatal sepsis and pneumoniaxprogesteronexkangaroo mother care (kmc)xcervical Cerclagexearly Breastfeedingxmultivitamins for hiv+ womenxthermal careamniotic Fluid volume assessmentxapplication of continued distending pressure or cpap to theantepartum Fetal Heart rate monitoring with cardiotocographylungs for rdscervical Pessaries to prevent preterm Birthxintravenous Immune Globulin (ivig)fetal biophysical test scoringxsurfactant therapy for rdshome versus hospital monitoring for high-risk Pregnanciesemollient therapyin-hospital fetal surveillance unithand washingintrapartum cardiotocography and pulse oximetryprophylaxis of Eye infectionmanagement of Gestational diabetes Mellitususe of appropriate low-cost technology (incubators, techniquesnon stress testing or vibroacoustic stimulationfor minimally invasive Intravenous access, protection against theuse of the partographexcessive use of oxygen)Fetal Movement monitoringheparin in Pregnancymanagement of Intrahepatic cholestasispelvimetryplasma Exchangepregnancy risk screeningultrasound scanning\nx indicates interventions described in the text.']	N/A	N/A	[('GO_0007602', 'phototransduction', 130, 'pregnancyGroup'), ('GO_0036260', 'RNA capping', 147, 'Intrapartum'), ('GO_0001966', 'thigmotaxis', 184, 'stillbirth'), ('GO_0009639', 'response to red or far red light', 195, 'XBirth'), ('CHEBI_5015', 'ferbam', 246, 'folateXUse'), ('GO_0007631', 'feeding behavior', 338, 'female'), ('GO_0002206', 'gene conversion of immunoglobulin genes', 345, 'genital mutilationXEmergency'), ('UBERON_3011048', 'genital system', 345, 'genital'), ('GO_0007565', 'female pregnancy', 465, 'pregnancy'), ('GO_0007631', 'feeding behavior', 475, 'XElective'), ('GO_0007612', 'learning', 498, 'labor'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 671, 'micronutrient'), ('GO_0007567', 'parturition', 713, 'deliveries'), ('CHEBI_30863', '5-azaorotic acid', 757, 'folate'), ('GO_0006260', 'DNA replication', 822, 'ripening'), ('CHEBI_16189', 'sulfate', 880, 'sulfate'), ('CHEBI_35222', 'inhibitor', 945, 'inhibitors'), ('CHEBI_28911', 'cob(III)alamin', 995, 'long-chain'), ('CHEBI_31593', 'fasudil hydrochloride', 1022, 'fatty acidsMagnesium sulphate'), ('GO_0007128', 'meiotic prophase I', 1069, 'preeclampsia'), ('CL_0000233', 'platelet', 1205, 'platelet'), ('CHEBI_33250', 'atom', 1214, 'agents'), ('GO_0007565', 'female pregnancy', 1224, 'pregnancy'), ('CHEBI_84369', 'cladoniamide D', 1245, 'aspirinAnti'), ('GO_0003059', 'positive regulation of the force of heart contraction by epinephrine', 1290, 'intrapartum'), ('CHEBI_81618', 'Pyrene-1,2-oxide', 1344, 'Anti-oxidantsXProphylactic'), ('CHEBI_36916', 'cation', 1371, 'corticosteroid'), ('GO_0007565', 'female pregnancy', 1397, 'preterm'), ('PR_000004370', 'asialoglycoprotein receptor 2', 1418, 'A'), ('CHEBI_17709', "5'-adenylyl sulfate", 1420, 'Beta-Carotene'), ('GO_0007565', 'female pregnancy', 1493, 'preterm'), ('GO_0007565', 'female pregnancy', 1555, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1700, 'pregnancy'), ('GO_0007567', 'parturition', 1778, 'Postnatal'), ('GO_0060156', 'milk ejection reflex', 1993, 'mother-to-child transmission'), ('CHEBI_52071', 'dextran', 2037, 'K'), ('UBERON_0001758', 'periodontium', 2129, 'periodontal'), ('GO_0007565', 'female pregnancy', 2236, 'pregnancies'), ('UBERON_0001893', 'telencephalon', 2376, 'cerclageXEarly'), ('GO_0002541', 'activation of plasma proteins involved in acute inflammatory response', 2391, 'breastfeedingXMultivitamins'), ('UBERON_0006314', 'bodily fluid', 2455, 'fluid'), ('UBERON_0000922', 'embryo', 2549, 'fetal'), ('UBERON_0000948', 'heart', 2555, 'heart'), ('UBERON_0001447', 'tarsal bone', 2620, 'pessaries'), ('GO_0001503', 'ossification', 2649, 'birthXIntravenous'), ('UBERON_0002405', 'immune system', 2667, 'immune'), ('CHEBI_5386', 'globin', 2674, 'globulin'), ('GO_1904106', 'protein localization to microvillus', 2792, 'pregnanciesEmollient'), ('UBERON_0000970', 'eye', 2929, 'eye'), ('GO_0007565', 'female pregnancy', 2956, 'gestational'), ('GO_0051332', 'meiotic S phase', 2977, 'mellitusUse'), ('UBERON_0034986', 'sacral nerve plexus', 3117, 'intravenous'), ('GO_0048484', 'enteric nervous system development', 3204, 'Fetal movement'), ('GO_0007547', 'germ-line processes downstream of sex determination signal', 3240, 'pregnancyManagement'), ('UBERON_0001226', 'major calyx', 3263, 'intrahepatic'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 3304, 'exchangePregnancy')]
PMC2984417	10/2010	S12-PMC2984417	['background\nPlacental abruption, the premature separation Of the Placenta before Delivery Of the Fetus, complicates approximately 1% of all Pregnancies [1-3].']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'Placental'), ('GO_0001503', 'ossification', 57, 'of ... placenta'), ('UBERON_0001987', 'placenta', 64, 'placenta'), ('GO_0009790', 'embryo development', 80, 'delivery of ... fetus'), ('GO_0007565', 'female pregnancy', 139, 'pregnancies')]
PMC3034879	12/2010	S156-PMC3034879	['furthermore, Vitamin D stimulates Osteoblastogenesis in Human Mesenchymal Stem Cells and Production Of Igf-1 in Osteoblasts [14].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0001503', 'ossification', 34, 'osteoblastogenesis'), ('NCBITaxon_9606', 'Homo sapiens', 56, 'human'), ('CL_0000134', 'mesenchymal stem cell', 62, 'mesenchymal stem cells'), ('UBERON_0003104', 'mesenchyme', 62, 'mesenchymal'), ('GO_0006412', 'translation', 89, 'production of IGF-1'), ('PR_000008929', 'interferon-related developmental regulator 1', 103, 'IGF-1'), ('CL_0000062', 'osteoblast', 112, 'osteoblasts')]
PMC3138750	7/2011	S55-PMC3138750	['in particular, Genes associated with Oxidative Phosphorylation (oxphos), Biosynthesis Of Steroids, and valine, leucine and isoleucine Degradation were found diminished in hp offspring.']	N/A	N/A	[('SO_0000704', 'gene', 15, 'genes'), ('GO_0006119', 'oxidative phosphorylation', 37, 'oxidative phosphorylation'), ('GO_0001503', 'ossification', 73, 'biosynthesis of steroids'), ('CHEBI_35341', 'steroid', 89, 'steroids'), ('GO_0009056', 'catabolic process', 134, 'degradation')]
PMC3138750	7/2011	S70-PMC3138750	['the numbers at vertical arrows are the number of probe-sets differentially Expressed between ap and hp offspring at the same Ontogenetic stage (arrows between boxes show direction of the comparisons; small arrows to top\u200a=\u200aup-regulated, small arrows to bottom\u200a=\u200adown-regulated probe-sets).10.1371/journal.pone.0021691.t001\n\ncaption (table-wrap): table 1\nsignificantly Regulated Transcripts of Metabolic pathways in Liver Tissue within different Ontogenetic stages (ingenuity pathway analysis).Ontogenetic stageregulated pathwayregulation p valueno.']	N/A	N/A	[('GO_0010467', 'gene expression', 75, 'expressed'), ('GO_0042476', 'odontogenesis', 125, 'ontogenetic'), ('GO_0065007', 'biological regulation', 367, 'regulated'), ('SO_0000673', 'transcript', 377, 'transcripts'), ('GO_0008152', 'metabolic process', 392, 'metabolic'), ('UBERON_0002107', 'liver', 414, 'liver'), ('UBERON_0000479', 'tissue', 420, 'tissue'), ('GO_0042476', 'odontogenesis', 444, 'ontogenetic'), ('GO_0001503', 'ossification', 492, 'Ontogenetic')]
PMC3138750	7/2011	S82-PMC3138750	['some Genes participating in Igf-1 Signaling, Biosynthesis Of Steroids and Growth Hormone Signaling were found to be decreased in hp Perinatal piglets.']	N/A	N/A	[('SO_0000704', 'gene', 5, 'genes'), ('GO_0038028', 'insulin receptor signaling pathway via phosphatidylinositol 3-kinase', 28, 'IGF-1 signaling'), ('PR_000008929', 'interferon-related developmental regulator 1', 28, 'IGF-1'), ('GO_0001503', 'ossification', 45, 'biosynthesis of steroids'), ('CHEBI_35341', 'steroid', 61, 'steroids'), ('GO_0090506', 'axillary shoot meristem initiation', 74, 'growth hormone signaling'), ('GO_0036268', 'swimming', 132, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 132, 'perinatal')]
PMC3183498	8/2011	S219-PMC3183498	['as one example, williams et al [73] used 21 Birth Defects surveillance systems data to analyze ntd rates by race ethnicity.']	N/A	N/A	[('GO_0001503', 'ossification', 44, 'birth defects')]
PMC3342123	3/2012	S62-PMC3342123	['caption (table-wrap): table 2\n\nsignificantly Regulated Transcripts of Metabolic pathways in Liver Tissue within different ontogenetic stages (ingenuity pathway analysis).Ontogenetic stageregulated pathwaydirection of Regulation p valueno.']	N/A	N/A	[('GO_0065007', 'biological regulation', 45, 'regulated'), ('SO_0000673', 'transcript', 55, 'transcripts'), ('GO_0008152', 'metabolic process', 70, 'metabolic'), ('UBERON_0002107', 'liver', 92, 'liver'), ('UBERON_0000479', 'tissue', 98, 'tissue'), ('GO_0001503', 'ossification', 170, 'Ontogenetic'), ('GO_0065007', 'biological regulation', 217, 'regulation')]
PMC3342123	3/2012	S90-PMC3342123	["Genes involved in 'Fatty Acid Metabolism', 'Biosynthesis Of Steroids', 'Synthesis and degradation Of Ketone Bodies', 'Glucocorticoid receptor signaling' as well as the 'Degradation Of valine, Leucine and isoleucine' were found to be up-regulated in lp offspring, while Genes associated with 'G1/S Checkpoint Regulation' were down-regulated."]	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_35366', 'fatty acid', 19, 'fatty acid'), ('GO_0006631', 'fatty acid metabolic process', 19, 'fatty acid metabolism'), ('GO_0001503', 'ossification', 44, 'biosynthesis of steroids'), ('CHEBI_35341', 'steroid', 60, 'steroids'), ('GO_0007416', 'synapse assembly', 72, 'synthesis ... of ketone bodies'), ('CHEBI_17087', 'ketone', 101, 'ketone'), ('CHEBI_24261', 'glucocorticoid', 118, 'glucocorticoid'), ('GO_0032499', 'detection of peptidoglycan', 169, 'degradation of ... leucine'), ('SO_0000704', 'gene', 269, 'genes'), ('GO_0042078', 'germ-line stem cell division', 292, 'G1/S checkpoint regulation')]
PMC3465343	10/2012	S88-PMC3465343	['furthermore, the Ossification Of the Second Phalange was either missing or greatly reduced in size in the Hindlimb of 12.1% (7/58) of vad neonates (table 3,fig.']	N/A	N/A	[('GO_0001503', 'ossification', 17, 'ossification'), ('UBERON_0010062', 'pharyngotympanic tube epithelium', 17, 'ossification of ... second phalange'), ('UBERON_0002103', 'hindlimb', 106, 'hindlimb')]
PMC3465343	10/2012	S106-PMC3465343	['(g) ventral view of the Ossification region showing normal Ossification development in a control fetus.']	N/A	N/A	[('GO_0001503', 'ossification', 24, 'ossification'), ('UBERON_0004747', 'supraoccipital bone', 24, 'ossification'), ('GO_0001503', 'ossification', 59, 'ossification'), ('UBERON_0004747', 'supraoccipital bone', 59, 'ossification')]
PMC3465343	10/2012	S107-PMC3465343	['(h) vad fetus, the Ossification Of the Second Phalange was either missing or greatly reduced in size.']	N/A	N/A	[('GO_0001503', 'ossification', 19, 'ossification'), ('UBERON_0010062', 'pharyngotympanic tube epithelium', 19, 'ossification of ... second phalange')]
PMC3471827	10/2012	S77-PMC3471827	['at 1 dpf in the trn Embryos, Eye or Brain Formation was almost completely halted, and a misshapen Tail was evident, whereas the ctr Embryos developed normally ( figure 3 ).']	N/A	N/A	[('UBERON_0000922', 'embryo', 20, 'embryos'), ('GO_0010467', 'gene expression', 29, 'eye ...'), ('UBERON_0000970', 'eye', 29, 'eye'), ('GO_0001503', 'ossification', 36, 'brain formation'), ('UBERON_0000955', 'brain', 36, 'brain'), ('UBERON_0002415', 'tail', 98, 'tail'), ('UBERON_0000922', 'embryo', 132, 'embryos')]
PMC3930526	2/2014	S143-PMC3930526	['for instance, zinc, contained in the multimicronutrient, is a necessary component for Placental Alkaline Phosphatase and a regulator of Insulin-Like Growth Factor I activity in Osteoblast Formation[57].']	N/A	N/A	[('PR_000003904', 'aldo-keto reductase family 1 member C2', 86, 'placental alkaline phosphatase'), ('UBERON_0001987', 'placenta', 86, 'placental'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 136, 'insulin-like growth factor I'), ('CL_0000062', 'osteoblast', 177, 'osteoblast'), ('GO_0001503', 'ossification', 177, 'osteoblast formation')]
PMC4071151	6/2014	S73-PMC4071151	['fetal Neurologic malformations result from failed Neural Tube closure and/or Neural Crest migration.']	N/A	N/A	[('UBERON_0001016', 'nervous system', 6, 'neurologic'), ('GO_0001503', 'ossification', 50, 'neural tube'), ('UBERON_0001049', 'neural tube', 50, 'neural tube'), ('UBERON_0002342', 'neural crest', 77, 'neural crest')]
PMC4071151	6/2014	S75-PMC4071151	['ntds resulting from failed complete Neural Tube closure at the rostral or caudal end lead to anencephaly and spina bifida [21].']	N/A	N/A	[('GO_0001503', 'ossification', 36, 'neural tube'), ('UBERON_0001049', 'neural tube', 36, 'neural tube')]
PMC4873529	3/2016	S61-PMC4873529	['results\n\neffect of maternal and offspring Obesogenic Feeding in phenotypical and Plasma biochemical parameters\nat 6\xa0months old, offspring weaned onto an Obesogenic diet had higher body weight (78\xa0%, p \u2009<\u20090.001) (fig.']	N/A	N/A	[('GO_0001503', 'ossification', 42, 'obesogenic'), ('GO_0007631', 'feeding behavior', 53, 'feeding'), ('UBERON_0001969', 'blood plasma', 81, 'plasma'), ('GO_0001503', 'ossification', 153, 'obesogenic')]
PMC4873529	3/2016	S71-PMC4873529	['effect of maternal and offspring Obesogenic Feeding in Pancreatic protein levels of upr mainstream regulators\nupr upstream regulator, Perk, did not show changes in protein level pattern by Maternal or offspring Obesogenic Feeding, with an elevated intersample variability (fig.']	N/A	N/A	[('GO_0001503', 'ossification', 33, 'obesogenic'), ('GO_0007631', 'feeding behavior', 44, 'feeding'), ('UBERON_0001264', 'pancreas', 55, 'pancreatic'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 134, 'PERK'), ('GO_0007618', 'mating', 189, 'maternal'), ('GO_0001503', 'ossification', 211, 'obesogenic'), ('GO_0007631', 'feeding behavior', 222, 'feeding')]
PMC4873529	3/2016	S80-PMC4873529	['effect of maternal and offspring Obesogenic Feeding on a phosphorylated and b total Perk and c their ratio, as well as on d phosphorylated and e total Eif2Α and f their ratio determined by western blot.']	N/A	N/A	[('GO_0001503', 'ossification', 33, 'obesogenic'), ('GO_0007631', 'feeding behavior', 44, 'feeding'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 84, 'PERK'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 151, 'EIF2α')]
PMC4873529	3/2016	S87-PMC4873529	['effect of maternal and Obesogenic Feeding on a phosphorylated Ire1Α, b total Ire1Α and c their ratio, as well as on d Spliced Xbp1 and e Unspliced Xbp1 and f their ratio determined by western blot.']	N/A	N/A	[('GO_0001503', 'ossification', 23, 'obesogenic'), ('GO_0007631', 'feeding behavior', 34, 'feeding'), ('PR_000029559', 'interleukin-36 beta', 62, 'IRE1α'), ('PR_000029559', 'interleukin-36 beta', 77, 'IRE1α'), ('GO_0008380', 'RNA splicing', 118, 'spliced'), ('GO_0033393', 'homogalacturonan catabolic process', 126, 'XBP1'), ('GO_0000240', 'diplotene', 137, 'unspliced'), ('GO_0033393', 'homogalacturonan catabolic process', 147, 'XBP1')]
PMC4873529	3/2016	S94-PMC4873529	['effect of maternal and offspring Obesogenic Feeding on a fragmented P50-Atf6, b P90-Atf6, and c their ratio determined by western blot; n \u2009=\u20093–4 Animals per group\n\neffect of maternal and offspring Obesogenic Feeding on Pancreatic mrna Expression of other er stress Mediators\nActivating Transcription Factor 4 (Atf4) and the proapoptotic transcription factor c/ebp Homologous protein (Chop) are mainly Regulated by the Perk-Eif2Α upr pathway.']	N/A	N/A	[('GO_0001503', 'ossification', 33, 'obesogenic'), ('GO_0007631', 'feeding behavior', 44, 'feeding'), ('PR_000003035', 'cellular tumor antigen p53', 68, 'p50'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 72, 'ATF6'), ('PR_000001245', 'rhodopsin', 80, 'p90'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 84, 'ATF6'), ('NCBITaxon_33208', 'Metazoa', 145, 'animals'), ('GO_0001503', 'ossification', 197, 'obesogenic'), ('GO_0007631', 'feeding behavior', 208, 'feeding'), ('UBERON_0001264', 'pancreas', 219, 'pancreatic'), ('GO_0010467', 'gene expression', 235, 'expression'), ('CHEBI_35222', 'inhibitor', 265, 'mediators'), ('PR_000003846', 'agouti-related protein', 275, 'Activating transcription factor 4'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 310, 'ATF4'), ('SO_0000857', 'homologous', 364, 'homologous'), ('PR_000005439', 'charged multivesicular body protein 5', 384, 'CHOP'), ('GO_0065007', 'biological regulation', 401, 'regulated'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 418, 'PERK'), ('PR_000006990', 'eukaryotic translation initiation factor 4E', 423, 'eIF2α')]
PMC4873529	3/2016	S95-PMC4873529	['both maternal and offspring Obesogenic Feeding significantly increased their Hepatic Gene Expression ( p \u2009<\u20090.05 and <0.01, respectively) (fig.']	N/A	N/A	[('GO_0001503', 'ossification', 28, 'obesogenic'), ('GO_0007631', 'feeding behavior', 39, 'feeding'), ('UBERON_0002107', 'liver', 77, 'hepatic'), ('GO_0010467', 'gene expression', 85, 'gene expression'), ('SO_0000704', 'gene', 85, 'gene')]
PMC4873529	3/2016	S97-PMC4873529	['indeed, the “double hit” of Obesogenic Feeding in mother and offspring resulted in significantly increased ob-ob Liver Atf4 and Chop messenger rna (mrna) Expressions in comparison with all other experimental groups ( p from <0.05 to <0.01 and from 157 to 217\xa0% for Atf4 and p from <0.01 to <0.001 and from 99 to 147\xa0% for Chop).']	N/A	N/A	[('GO_0001503', 'ossification', 28, 'obesogenic'), ('GO_0007631', 'feeding behavior', 39, 'feeding'), ('UBERON_0002107', 'liver', 113, 'liver'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 119, 'ATF4'), ('CHEBI_63057', 'EHNA', 128, 'CHOP'), ('PR_000005439', 'charged multivesicular body protein 5', 128, 'CHOP'), ('GO_0010467', 'gene expression', 154, 'expressions'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 265, 'ATF4'), ('CHEBI_63057', 'EHNA', 322, 'CHOP')]
PMC4873529	3/2016	S100-PMC4873529	['effect of maternal and offspring Obesogenic Feeding on a Atf4, b Chop, c Edem, d Herp, e Wsf1, and f Insulin.']	N/A	N/A	[('GO_0001503', 'ossification', 33, 'obesogenic'), ('GO_0007631', 'feeding behavior', 44, 'feeding'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 57, 'ATF4'), ('CHEBI_63057', 'EHNA', 65, 'CHOP'), ('PR_000005439', 'charged multivesicular body protein 5', 65, 'CHOP'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 73, 'EDEM'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 81, 'HERP'), ('PR_000017453', 'protein Wnt-9b', 89, 'WSF1'), ('PR_000045358', 'insulin family protein', 101, 'insulin')]
PMC4873529	3/2016	S116-PMC4873529	['effects of maternal and offspring Obesogenic Feeding on a Grp78 and b Chop determined by western blot; n \u2009=\u20093–4 Animals per group\n\neffect of maternal and offspring obesogenic feeding on Autophagy regulators\nNafpd and Pancreatic Carcinogenesis are kept going by derangement of Proliferation, Apoptosis, Metabolism, and Autophagy [33].']	N/A	N/A	[('GO_0001503', 'ossification', 34, 'obesogenic'), ('GO_0007631', 'feeding behavior', 45, 'feeding'), ('PR_000008210', 'glutathione peroxidase 1', 58, 'GRP78'), ('CHEBI_63057', 'EHNA', 70, 'CHOP'), ('PR_000005439', 'charged multivesicular body protein 5', 70, 'CHOP'), ('NCBITaxon_33208', 'Metazoa', 112, 'animals'), ('GO_0006914', 'autophagy', 186, 'autophagy'), ('PR_000010990', 'N-alpha-acetyltransferase 16, NatA auxiliary subunit', 207, 'NAFPD'), ('GO_0009834', 'plant-type secondary cell wall biogenesis', 217, 'pancreatic carcinogenesis'), ('UBERON_0001264', 'pancreas', 217, 'pancreatic'), ('GO_0008283', 'cell proliferation', 276, 'proliferation'), ('GO_0006915', 'apoptotic process', 291, 'apoptosis'), ('GO_0008152', 'metabolic process', 302, 'metabolism'), ('GO_0006914', 'autophagy', 318, 'autophagy')]
PMC4892656	6/2016	S35-PMC4892656	['after lambing, the two siblings were assigned to separate diets, either a conventional (conv; n = 35; 16 males, 19 females) or an Obesogenic high-Carbohydrate-high-fat (Hchf; n = 35; 18 males, 17 females) diet from 3-days until 6-months of age.']	N/A	N/A	[('GO_0001503', 'ossification', 130, 'obesogenic'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 146, 'carbohydrate'), ('CHEBI_17883', 'hydrogen chloride', 169, 'HCHF')]
PMC4954778	7/2016	S0-PMC4954778	['Obesogenic phenotype of offspring of dams Fed a high multivitamin diet is prevented by a post-weaning high multivitamin or high Folate diet\n\nabstract\n\nbackground\nhigh multivitamin (10-fold ain-93g, hv) diets Fed during Pregnancy to wistar Rats increase characteristics of Metabolic syndrome in offspring when weaned to the recommended vitamin (rv) diet.']	N/A	N/A	[('GO_0001503', 'ossification', 0, 'Obesogenic'), ('GO_0007631', 'feeding behavior', 42, 'fed'), ('CHEBI_30863', '5-azaorotic acid', 128, 'folate'), ('GO_0007631', 'feeding behavior', 208, 'fed'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 239, 'rats'), ('GO_0008152', 'metabolic process', 272, 'metabolic')]
PMC4996908	5/2016	S50-PMC4996908	['under the influence of the overlying dorsal Neurectoderm, it differentiates into fat that\xa0prevents further Neural Tube closure.']	N/A	N/A	[('UBERON_0002346', 'neurectoderm', 44, 'neurectoderm'), ('GO_0001503', 'ossification', 107, 'neural tube'), ('UBERON_0001049', 'neural tube', 107, 'neural tube')]
PMC5000726	8/2016	S73-PMC5000726	['activation of sirt1 in Mesenchymal Stem Cells (Mscs) promotes Osteogenic differentiation, blocking Adipocyte differentiation.']	N/A	N/A	[('CL_0000134', 'mesenchymal stem cell', 23, 'mesenchymal stem cells'), ('UBERON_0003104', 'mesenchyme', 23, 'mesenchymal'), ('CL_0000186', 'myofibroblast cell', 47, 'MSCs'), ('GO_0001503', 'ossification', 62, 'osteogenic'), ('CL_0000136', 'fat cell', 99, 'adipocyte')]
PMC5000726	8/2016	S97-PMC5000726	['Setdb1 and Ezh2 are two kmts that inhibit Osteogenic differentiation of Mscs via blocking Runx2 , Transcription factor 7 ( Tcf7 ), and Osterix ( Osx ) transcription, and promote Adipogenesis of Mscs by inducing the Expression of Peroxisome Proliferator-Activated Receptors Gamma ( Pparγ ), Myocyte Enhancer factor 2 interacting transcriptional repressor ( Mitr ), and wnt-related Genes [29].']	N/A	N/A	[('PR_000014730', 'splicing factor 1', 0, 'SETDB1'), ('PR_000007228', 'ETS translocation variant 5', 11, 'EZH2'), ('GO_0001503', 'ossification', 42, 'osteogenic'), ('CL_0000186', 'myofibroblast cell', 72, 'MSCs'), ('PR_000014339', 'radial spoke head 14 homolog', 90, 'RUNX2'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 98, 'transcription'), ('PR_000008440', 'heart- and neural crest derivatives-expressed protein 2', 119, '7'), ('PR_000016190', 'trichohyalin-like protein 1', 123, 'TCF7'), ('PR_000000124', 'ribosomal protein S6 kinase beta-2', 135, 'Osterix'), ('PR_000012064', 'organic solute transporter subunit alpha', 145, 'OSX'), ('GO_0060612', 'adipose tissue development', 178, 'adipogenesis'), ('CL_0000186', 'myofibroblast cell', 194, 'MSCs'), ('GO_0010467', 'gene expression', 215, 'expression'), ('GO_0005777', 'peroxisome', 229, 'peroxisome'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 229, 'peroxisome proliferator-activated receptors gamma'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 281, 'PPARγ'), ('CL_0000187', 'muscle cell', 290, 'myocyte'), ('SO_0000165', 'enhancer', 298, 'enhancer'), ('PR_000001995', 'C-C motif chemokine 23', 356, 'MITR'), ('SO_0000704', 'gene', 380, 'genes')]
PMC5000726	8/2016	S143-PMC5000726	['all these Mirnas Control Osteogenic differentiation at different levels, blocking the Osteoblast lineage progression of committed pre-Osteoblasts or directing multi-potent Mesenchymal Stem Cells toward Adipogenic differentiation.']	N/A	N/A	[('SO_0000276', 'miRNA', 10, 'miRNAs'), ('GO_0065007', 'biological regulation', 17, 'control'), ('GO_0001503', 'ossification', 25, 'osteogenic'), ('CL_0000062', 'osteoblast', 86, 'osteoblast'), ('CL_0000062', 'osteoblast', 134, 'osteoblasts'), ('CL_0000134', 'mesenchymal stem cell', 172, 'mesenchymal stem cells'), ('UBERON_0003104', 'mesenchyme', 172, 'mesenchymal'), ('GO_0060612', 'adipose tissue development', 202, 'adipogenic')]
PMC5000726	8/2016	S145-PMC5000726	['mir-2861 and mir-3960 are transcribed together from the same Mirna Polycistron during Bmp2-induced Osteogenesis.']	N/A	N/A	[('SO_0000276', 'miRNA', 61, 'miRNA'), ('SO_0000553', 'polyA_site', 67, 'polycistron'), ('PR_000000164', 'BMP2', 86, 'BMP2'), ('GO_0001503', 'ossification', 99, 'osteogenesis')]
PMC5000726	8/2016	S161-PMC5000726	['Mir-29A Gene Expression is enhanced by Canonical Wnt Signalling, and its Expression is increased during Osteogenic differentiation of Mesenchymal Osteoblast precursors [47].']	N/A	N/A	[('PR_000000123', 'ribosomal protein S6 kinase beta-1', 0, 'miR-29a'), ('SO_0001434', 'cassette_pseudogene', 0, 'miR'), ('GO_0010467', 'gene expression', 8, 'gene expression'), ('SO_0000704', 'gene', 8, 'gene'), ('GO_0060070', 'canonical Wnt signaling pathway', 39, 'canonical Wnt signalling'), ('GO_0010467', 'gene expression', 73, 'expression'), ('GO_0001503', 'ossification', 104, 'osteogenic'), ('CL_0000134', 'mesenchymal stem cell', 134, 'mesenchymal'), ('UBERON_0003104', 'mesenchyme', 134, 'mesenchymal'), ('CL_0000062', 'osteoblast', 146, 'osteoblast')]
PMC5000726	8/2016	S165-PMC5000726	['mir-335-5p activates Wnt Signalling and promotes Osteogenic differentiation by downregulating Dkk1, and is highly Expressed in both Osteoblasts and Hypertrophic Chondrocytes during Embryogenesis [49].']	N/A	N/A	[('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 4, '335'), ('GO_0016055', 'Wnt signaling pathway', 21, 'Wnt signalling'), ('GO_0001503', 'ossification', 49, 'osteogenic'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 94, 'DKK1'), ('GO_0010467', 'gene expression', 114, 'expressed'), ('CL_0000062', 'osteoblast', 132, 'osteoblasts'), ('CL_0000743', 'hypertrophic chondrocyte', 148, 'hypertrophic chondrocytes'), ('GO_0009790', 'embryo development', 181, 'embryogenesis')]
PMC5000726	8/2016	S169-PMC5000726	['inactivation of Apc by Mir-27 induces the accumulation of Β-Catenin, its Translocation Into the Nucleus, and the transcription of wnt-Regulated Genes, resulting in a promotion of Osteogenesis.']	N/A	N/A	[('PR_000004122', 'adenomatous polyposis coli protein', 16, 'APC'), ('PR_000005450', 'chromatin accessibility complex protein 1', 23, 'miR-27'), ('PR_000002198', 'catenin beta-1', 58, 'β-catenin'), ('GO_0006409', 'tRNA export from nucleus', 73, 'translocation into ... nucleus'), ('GO_0005634', 'nucleus', 96, 'nucleus'), ('GO_0065007', 'biological regulation', 133, '-regulated'), ('SO_0000704', 'gene', 144, 'genes'), ('GO_0001503', 'ossification', 179, 'osteogenesis')]
PMC5065689	10/2016	S126-PMC5065689	['2003 [76]europe (ecs)cohort2414birthcart vs. no Art vs. Azt monotherapypreterm Birthincreased risk Preterm Birth (or=2.66, 95% ci: 1.52–4.67 for cart without pi; or=4.14, 95% ci: 2.36–7.23 for cart with Pi) with carttownsend et al .']	N/A	N/A	[('CHEBI_53233', '3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide', 48, 'ART'), ('CHEBI_59132', 'antigen', 56, 'AZT'), ('GO_0001503', 'ossification', 79, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 99, 'preterm birth'), ('CHEBI_16200', 'questin', 203, 'PI')]
PMC5065689	10/2016	S128-PMC5065689	['2012 [88]botswanacohort13,181birthcart vs. Azt monotherapypre-Pregnancy cart initiation vs. all otherspreterm Birthincreased risk Preterm Birth with Cart (or=1.4, 95% ci: 1.2–1.8) and pre-Pregnancy Cart initiation (or=1.2, 95% ci: 1.1–1.4)sibiude et al .']	N/A	N/A	[('CHEBI_59132', 'antigen', 43, 'AZT'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('GO_0001503', 'ossification', 110, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 130, 'preterm birth'), ('CHEBI_34018', '(S)-AMPA', 149, 'cART'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy'), ('CHEBI_34018', '(S)-AMPA', 198, 'cART')]
PMC5065689	10/2016	S129-PMC5065689	['2012 [91]france (epf)cohort1253birthcart vs. azt monotherapyritonavir boosted pi vs. non-Ritonavir boosted pipreterm Birthincreased risk Preterm Birth with cart (or=1.69, 95% ci: 1.38–2.07)increased risk Preterm Birth with Ritonavir boosted pi (or=2.03; 95% ci: 1.06–3.89)short et al .']	N/A	N/A	[('CHEBI_45409', 'ritonavir', 89, 'ritonavir'), ('GO_0001503', 'ossification', 117, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 137, 'preterm'), ('GO_0007567', 'parturition', 145, 'birth'), ('GO_0007565', 'female pregnancy', 204, 'preterm birth'), ('CHEBI_45409', 'ritonavir', 223, 'ritonavir')]
PMC5065689	10/2016	S130-PMC5065689	['2014 [92]ukcohort331birthcart vs. Azt monotherapypreterm Birthincreased risk Preterm Birth with cart (or=5.0, 95% ci: 1.5–16.8)lopez et al .']	N/A	N/A	[('CHEBI_59132', 'antigen', 34, 'AZT'), ('GO_0001503', 'ossification', 57, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 77, 'preterm'), ('GO_0007567', 'parturition', 85, 'birth')]
PMC5065689	10/2016	S131-PMC5065689	['2012 [93]spainmatched cohort1557birthhiv+/arv+ or arv- vs. hiv-cart during 2ndhalf of Pregnancy vs. untreatedpreterm Birthincreased risk Preterm Birth with maternal hiv infection (arv+/−) (or=2.5, 95% ci: 1.5–3.9)increased risk Iatrogenic Preterm Birth with cart during 2ndhalf of Pregnancy (or=6.16, 95% ci: 1.42–26.80) Pi exposure cotter et al .']	N/A	N/A	[('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0001503', 'ossification', 117, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 137, 'preterm birth'), ('GO_0001835', 'blastocyst hatching', 228, 'iatrogenic'), ('GO_0007565', 'female pregnancy', 239, 'preterm birth'), ('GO_0007565', 'female pregnancy', 281, 'pregnancy'), ('CHEBI_16200', 'questin', 321, 'PI')]
PMC5065689	10/2016	S132-PMC5065689	['2006 [94]usregistry1337birthpi-based cart vs. non pi-based cartcart vs. Azt monotherapyany art vs. nonepreterm Birthincreased risk Preterm Birth (or=1.8, 95% ci: 1.1–3.0) for pi vs. non pi-based cartno increased risk for Preterm Birth with cart vs. azt monotherapy or art vs. no artschulte et al .']	N/A	N/A	[('CHEBI_59132', 'antigen', 72, 'AZT'), ('GO_0001503', 'ossification', 111, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 131, 'preterm birth'), ('GO_0007565', 'female pregnancy', 221, 'preterm'), ('GO_0007567', 'parturition', 229, 'birth')]
PMC5065689	10/2016	S133-PMC5065689	['2007 [95]us (psd)registry8793birthpi-based cart vs. dual therapy artno art vs. dual therapy artpreterm Birthincreased risk Preterm Birth (or=1.21, 95% ci: 1.04–1.40)increased risk Preterm Birth (or=1.16, 95% ci: 1.02–1.32)grosch-woerner et al .']	N/A	N/A	[('GO_0001503', 'ossification', 103, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 123, 'preterm birth'), ('GO_0007565', 'female pregnancy', 180, 'preterm birth')]
PMC5065689	10/2016	S134-PMC5065689	['2008 [96]germanycohort183birthpi-based Cart vs. Azt monotherapypreterm Birthincreased risk Preterm Birth (or=3.4, 95% ci: 1.1–10.2) with Pi-based cartszyld et al .']	N/A	N/A	[('CHEBI_34018', '(S)-AMPA', 39, 'cART'), ('CHEBI_59132', 'antigen', 48, 'AZT'), ('GO_0001503', 'ossification', 71, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 91, 'preterm birth'), ('CHEBI_16200', 'questin', 137, 'PI')]
PMC5065689	10/2016	S137-PMC5065689	['2013 [74]us (phacs)cohort1869birth1sttrimester pi vs. nnrti vs. ≥3 nrtis-based artpreterm Birthincreased risk Preterm Birth with 1st Trimester pi (or=1.55, 95% ci: 1.16–2.07) congenital anomalies ecs.']	N/A	N/A	[('GO_0001503', 'ossification', 90, 'birthIncreased'), ('GO_0007565', 'female pregnancy', 110, 'preterm birth'), ('GO_0009294', 'DNA mediated transformation', 133, 'trimester')]
PMC5143410	12/2016	S25-PMC5143410	['peripheral Ossifying fibroma resembles pg clinically but occurs exclusively in the Gingiva.']	N/A	N/A	[('GO_0001503', 'ossification', 11, 'ossifying'), ('UBERON_1000011', 'labial commissure', 11, 'ossifying'), ('UBERON_0001828', 'gingiva', 83, 'gingiva')]
PMC5143410	12/2016	S26-PMC5143410	['although peripheral Ossifying fibroma exhibits features of vascular Proliferation and Ossification, it mostly contains Fibroblasts and Stroma.']	N/A	N/A	[('GO_0001503', 'ossification', 20, 'ossifying'), ('UBERON_1000011', 'labial commissure', 20, 'ossifying'), ('GO_0008283', 'cell proliferation', 68, 'proliferation'), ('GO_0001503', 'ossification', 86, 'ossification'), ('CL_0000057', 'fibroblast', 119, 'fibroblasts'), ('UBERON_0003891', 'stroma', 135, 'stroma')]
PMC5347102	3/2017	S259-PMC5347102	['the practical outcomes of Colostrum Intake on Development Of neonatal Reproductive Tissue is nicely illustrated in an article by vallet et al.']	N/A	N/A	[('GO_0065007', 'biological regulation', 26, 'colostrum'), ('GO_0007631', 'feeding behavior', 36, 'intake'), ('GO_0001503', 'ossification', 46, 'development of ... reproductive tissue'), ('UBERON_0003909', 'sinusoid', 70, 'reproductive tissue')]
PMC5410409	4/2017	S55-PMC5410409	['supplementation with Vitamin A and Vitamin C during Pregnancy had no preventive effect on the development Of Wheezing in the child [7].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin C'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0001503', 'ossification', 106, 'of wheezing')]
PMC5472316	6/2017	S102-PMC5472316	['the zone of Ossification (Iv) is the region of cartilage transition to bone.']	N/A	N/A	[('GO_0001503', 'ossification', 12, 'ossification'), ('UBERON_2005049', 'prosencephalic artery', 26, 'IV')]
PMC5472316	6/2017	S215-PMC5472316	['the Reserve and Ossification Zones were free from the reaction in the control Animals.']	N/A	N/A	[('UBERON_0003436', 'shoulder nerve', 4, 'reserve'), ('GO_0001503', 'ossification', 16, 'ossification'), ('UBERON_2000620', 'autopalatine', 16, 'ossification zones'), ('NCBITaxon_33208', 'Metazoa', 78, 'animals')]
PMC5472316	6/2017	S217-PMC5472316	['the Reserve and Ossification Zones also were free from the reaction.10.1371/journal.pone.0179693.g003\n\ncaption (fig): fig 3\nthe immunohistochemical analysis of the Expression of Osteoprotegerin from the Proliferative zone of Growth Plate.']	N/A	N/A	[('UBERON_0003436', 'shoulder nerve', 4, 'reserve'), ('GO_0001503', 'ossification', 16, 'ossification'), ('UBERON_2000620', 'autopalatine', 16, 'ossification zones'), ('GO_0010467', 'gene expression', 164, 'expression'), ('PR_000011593', 'ovarian cancer-related protein 1', 178, 'osteoprotegerin'), ('UBERON_0003888', 'extraembryonic coelomic cavity', 203, 'proliferative'), ('UBERON_0002516', 'epiphyseal plate', 225, 'growth plate')]
PMC5941617	5/2018	S246-PMC5941617	['besides the direct Regulation Of Calcium-Phosphorus Metabolism, Vitamin D also indirectly promotes bone mass accrual stimulating the Development Of Muscle Tissue [196–198].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'regulation of'), ('CHEBI_30272', 'arsonium', 33, 'calcium-phosphorus'), ('GO_0050655', 'dermatan sulfate proteoglycan metabolic process', 33, 'calcium-phosphorus metabolism'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0001503', 'ossification', 133, 'development of muscle tissue'), ('UBERON_0002385', 'muscle tissue', 148, 'muscle tissue')]
